Syncell

Syncell develops next-generation subcellular protein purification and spatial proteomics analysis technology. Their Microscoop platform enables high-precision, unbiased spatial proteomic discovery, helping researchers identify disease biomarkers and drug targets. This technology is applicable across various research areas, including oncology and neurodegenerative diseases.

Buy Funded Startups lists

Funding Round: Series A

Funding Amount: $15M

Date: 11-Dec-2024

Investors: Taiwan Capital

Markets: Life Sciences, Biotechnology, Proteomics, Spatial Biology

HQ: Taipei, Taiwan, Taiwan

Founded: 2020

Website: https://syncell.com

LinkedIn: https://www.linkedin.com/company/syncell/

Twitter: https://twitter.com/SyncellInc

Instagram: